Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_assertion type Assertion NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_head.
- NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_assertion description "[The present study has shown for the first time that phosphorylation of ER-alpha Ser167, but not Ser118, and expression of PRA and PRB, as well as ER-alpha and PR in primary breast tumors are predictive of response to endocrine therapy, whereas expression of ER-beta1 and ER-betacx/beta2 did not affect response to the therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_provenance.
- NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_assertion evidence source_evidence_literature NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_provenance.
- NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_assertion SIO_000772 16168121 NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_provenance.
- NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_assertion wasDerivedFrom befree-20140225 NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_provenance.
- NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_assertion wasGeneratedBy ECO_0000203 NP877845.RAC2T7i9LYqwc-cN4TATd_1MNqUZQh46u0arEsrzafD9E130_provenance.